Free Trial
NYSE:CNC

Centene (CNC) Stock Price, News & Analysis

Centene logo
$61.97 +2.37 (+3.98%)
Closing price 03:59 PM Eastern
Extended Trading
$61.78 -0.19 (-0.30%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Centene Stock (NYSE:CNC)

Advanced

Key Stats

Today's Range
$59.47
$62.10
50-Day Range
$31.72
$61.97
52-Week Range
$25.08
$62.10
Volume
5.74 million shs
Average Volume
5.10 million shs
Market Capitalization
$30.60 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$58.94
Consensus Rating
Hold

Company Overview

Centene Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
60th Percentile Overall Score

CNC MarketRank™: 

Centene scored higher than 60% of companies evaluated by MarketBeat, and ranked 417th out of 868 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Centene has received a consensus rating of Hold. The company's average rating score is 2.37, and is based on 1 strong buy rating, 7 buy ratings, 9 hold ratings, and 2 sell ratings.

  • Upside/Downside

    The consensus price target for Centene is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Centene has been the subject of 18 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Centene's stock forecast and price target.
  • Earnings Growth

    Earnings for Centene are expected to grow by 27.83% in the coming year, from $3.45 to $4.41 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Centene is -4.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Centene is -4.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Centene has a PEG Ratio of 0.47. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Centene has a P/B Ratio of 1.52. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Centene's valuation and earnings.
  • Percentage of Shares Shorted

    3.08% of the float of Centene has been sold short.
  • Short Interest Ratio / Days to Cover

    Centene has a short interest ratio ("days to cover") of 2.36, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Centene has recently decreased by 0.58%, indicating that investor sentiment is improving.
  • Dividend Yield

    Centene does not currently pay a dividend.

  • Dividend Growth

    Centene does not have a long track record of dividend growth.

  • News Sentiment

    Centene has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Centene this week, compared to 10 articles on an average week.
  • Search Interest

    Only 23 people have searched for CNC on MarketBeat in the last 30 days. This is a decrease of -34% compared to the previous 30 days.
  • MarketBeat Follows

    Only 3 people have added Centene to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Centene insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.37% of the stock of Centene is held by insiders.

  • Percentage Held by Institutions

    93.63% of the stock of Centene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Centene's insider trading history.
Receive CNC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Centene and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CNC Stock News Headlines

Centene (CNC) Receives a Buy from Bernstein
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
Deutsche Bank upgrades Centene (CNC)
Centene Raises EPS Outlook Amid Cost Pressures
See More Headlines

CNC Stock Analysis - Frequently Asked Questions

Centene's stock was trading at $41.18 on January 1st, 2026. Since then, CNC stock has increased by 50.5% and is now trading at $61.97.

Centene Corporation (NYSE:CNC) issued its quarterly earnings results on Tuesday, April, 28th. The company reported $3.37 earnings per share for the quarter, topping analysts' consensus estimates of $2.23 by $1.14. The business's revenue for the quarter was up 7.1% compared to the same quarter last year.
Read the conference call transcript
.

Centene shares split before market open on Wednesday, February 6th 2019.The 2-1 split was announced on Tuesday, February 5th 2019. The newly minted shares were issued to shareholders after the market closes on Tuesday, February 5th 2019. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Centene subsidiaries include these companies: Magellan Health Inc, PANTHERx Rare Pharmacy, Apixio, WellCare Health Plans, Community Medical Group, MHM, Fidelis Care, and others.

Top institutional shareholders of Centene include Arrowstreet Capital Limited Partnership (1.37%), Amundi (0.78%), Bank of America Corp DE (0.78%) and Assenagon Asset Management S.A. (0.78%). Insiders that own company stock include Sarah London, Andrew Lynn Asher, Kenneth J Fasola, Theodore R Samuels II, Christopher J Coughlin, Lori Jean Robinson and H James Dallas.
View institutional ownership trends
.

Shares of CNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Centene investors own include Humana (HUM), NVIDIA (NVDA), Meta Platforms (META), American Water Works (AWK), Salesforce (CRM), Advanced Micro Devices (AMD) and Verizon Communications (VZ).

Company Calendar

Last Earnings
4/28/2026
Today
6/01/2026
Next Earnings (Estimated)
7/28/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - HMO
Sub-Industry
Managed Health Care
Current Symbol
NYSE:CNC
CIK
1071739
Employees
61,100
Year Founded
1984

Price Target and Rating

High Price Target
$80.00
Low Price Target
$37.00
Potential Upside/Downside
-4.9%
Consensus Rating
Hold
Rating Score (0-4)
2.37
Research Coverage
19 Analysts

Profitability

EPS (Trailing Twelve Months)
($13.14)
Trailing P/E Ratio
N/A
Forward P/E Ratio
17.96
P/E Growth
0.47
Net Income
-$6.67 billion
Net Margins
-3.25%
Pretax Margin
-3.22%
Return on Equity
5.57%
Return on Assets
1.54%

Debt

Debt-to-Equity Ratio
0.76
Current Ratio
1.12
Quick Ratio
1.12

Sales & Book Value

Annual Sales
$194.78 billion
Price / Sales
0.16
Cash Flow
$4.87 per share
Price / Cash Flow
12.72
Book Value
$40.76 per share
Price / Book
1.52

Miscellaneous

Outstanding Shares
493,800,000
Free Float
491,970,000
Market Cap
$30.60 billion
Optionable
Optionable
Beta
1.09

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NYSE:CNC) was last updated on 6/1/2026 by MarketBeat.com Staff.
From Our Partners